Encyclopaeda Britannica

19, November, 2018

Encyclopaedia Britannica
This text is about Encyclopaedia Britannica which is designed for general public. The purpose is to introduce the company of Britannica and the text is divided into four main sections.

The first section is written about the history Britannica. It was Scottish-founded but now it is an American company and it was founded in Edinbrugh, scotland in 1768. Colin Macfraquhar and Andrew Bell were the founters and the headquarters location are in Chicago and US.

The second section is written about Sears Roebuck who was author and founder the Encyclopaedia Britannica In 1920, the trademark and publication rights were sold to him  and he held them till 1943.

The third section is written bout William Benton who published Britannica from 1943 untill his death in 1973. After his death, his widow Helen Benton continued to mannage the Britannca untill it was sold to Jacqui Safra in 1996.

The final section is about Jacqui Safra who gained the ownership of Britannica in 1996. Under her ownership, the company has experienced some financial woes with freelance contributors who were waiting up for six months payments. In 2002, Britannica told employees it would raise the contribution paid into their accounts and then eliminated them entirely and now theu are privately held company.

REM Sleep Behavior Disorder Virtual Issue

                           

REM Sleep Behavior Disorder Virtual Issue

I am writing the summary of REM sleep behavior disorder 

The journal article is about sleep behavior disorder that has two authors named Carlos H and Schenck, M.D.

Over the past two years , the authors have aspirated the most important articles on REM, sleep behavior disorder (RBD)  that were published in SLEEP. These articles show the breadth and depth of the clinical research on RED which inclusive new discoveries in epidemiology.

The authors of these articles have done great and successful research that have help the speed of knowledge on RED with the clinical aims of of improving patient care, lessening the burden communicated with neurodegenerative disorders, and also the slowing down or stopping the improvement from "idiopathic" or "isolated" RBD to the emergence of alpha-synucleinopathy neurodegenerative disorders.

Oxford Journal Articles